A detailed history of Sector Gamma As transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sector Gamma As holds 420,163 shares of GILD stock, worth $37.1 Million. This represents 11.25% of its overall portfolio holdings.

Number of Shares
420,163
Previous 265,619 58.18%
Holding current value
$37.1 Million
Previous $19.5 Million 48.17%
% of portfolio
11.25%
Previous 5.74%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$63.15 - $72.88 $9.76 Million - $11.3 Million
154,544 Added 58.18%
420,163 $28.8 Million
Q1 2024

May 08, 2024

SELL
$71.58 - $87.29 $8.36 Million - $10.2 Million
-116,743 Reduced 30.53%
265,619 $19.5 Million
Q4 2023

Feb 05, 2024

SELL
$73.27 - $83.09 $17.6 Million - $20 Million
-240,761 Reduced 38.64%
382,362 $31 Million
Q3 2023

Nov 06, 2023

BUY
$73.94 - $80.67 $1.61 Million - $1.76 Million
21,756 Added 3.62%
623,123 $46.7 Million
Q2 2023

Aug 09, 2023

BUY
$76.01 - $86.7 $4.45 Million - $5.08 Million
58,594 Added 10.8%
601,367 $46.3 Million
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $4.12 Million - $4.69 Million
-53,263 Reduced 8.94%
542,773 $45 Million
Q4 2022

Feb 07, 2023

SELL
$62.32 - $89.47 $17.9 Million - $25.7 Million
-287,070 Reduced 32.51%
596,036 $51.2 Million
Q3 2022

Nov 09, 2022

BUY
$59.54 - $68.01 $2.36 Million - $2.7 Million
39,679 Added 4.7%
883,106 $54.5 Million
Q2 2022

Aug 05, 2022

BUY
$57.72 - $65.01 $9.34 Million - $10.5 Million
161,889 Added 23.75%
843,427 $52.1 Million
Q1 2022

May 06, 2022

BUY
$57.92 - $72.58 $22.3 Million - $27.9 Million
384,483 Added 129.43%
681,538 $40.5 Million
Q4 2021

Feb 08, 2022

SELL
$64.88 - $73.64 $4.8 Million - $5.45 Million
-74,030 Reduced 19.95%
297,055 $21.6 Million
Q3 2021

Oct 29, 2021

SELL
$67.69 - $73.03 $14 Million - $15.1 Million
-206,283 Reduced 35.73%
371,085 $25.9 Million
Q2 2021

Aug 04, 2021

SELL
$63.47 - $69.35 $6.43 Million - $7.02 Million
-101,265 Reduced 14.92%
577,368 $39.8 Million
Q1 2021

May 10, 2021

SELL
$60.0 - $68.46 $9.57 Million - $10.9 Million
-159,507 Reduced 19.03%
678,633 $43.9 Million
Q4 2020

Feb 10, 2021

BUY
$56.65 - $64.55 $20.5 Million - $23.3 Million
361,046 Added 75.68%
838,140 $48.8 Million
Q3 2020

Nov 09, 2020

BUY
$62.1 - $78.08 $2.69 Million - $3.38 Million
43,310 Added 9.98%
477,094 $30.1 Million
Q2 2020

Aug 07, 2020

BUY
$72.34 - $84.0 $17 Million - $19.7 Million
234,365 Added 117.52%
433,784 $33.4 Million
Q1 2020

May 11, 2020

SELL
$62.63 - $80.22 $13.5 Million - $17.3 Million
-216,186 Reduced 52.02%
199,419 $14.9 Million
Q4 2019

Feb 12, 2020

SELL
$61.62 - $67.78 $3.66 Million - $4.03 Million
-59,451 Reduced 12.51%
415,605 $27 Million
Q3 2019

Nov 05, 2019

BUY
$62.51 - $69.0 $1.88 Million - $2.07 Million
30,000 Added 6.74%
475,056 $30.1 Million
Q2 2019

Jul 31, 2019

SELL
$61.87 - $69.38 $8.27 Million - $9.27 Million
-133,681 Reduced 23.1%
445,056 $30.1 Million
Q1 2019

May 13, 2019

BUY
$62.53 - $70.05 $9.03 Million - $10.1 Million
144,380 Added 33.24%
578,737 $37.6 Million
Q4 2018

Feb 12, 2019

BUY
$60.54 - $79.0 $6.73 Million - $8.78 Million
111,170 Added 34.4%
434,357 $27.2 Million
Q3 2018

Nov 15, 2018

BUY
$71.28 - $78.92 $9.77 Million - $10.8 Million
137,024 Added 73.6%
323,187 $25 Million
Q3 2018

Nov 08, 2018

SELL
$71.28 - $78.92 $7.52 Million - $8.32 Million
-105,437 Reduced 36.16%
186,163 $14.4 Million
Q2 2018

Aug 02, 2018

BUY
$64.88 - $75.68 $12.2 Million - $14.2 Million
188,100 Added 181.74%
291,600 $20.7 Million
Q1 2018

May 09, 2018

SELL
$72.84 - $88.8 $18.5 Million - $22.6 Million
-254,390 Reduced 71.08%
103,500 $7.8 Million
Q4 2017

Feb 12, 2018

BUY
$71.15 - $83.52 $1.58 Million - $1.85 Million
22,200 Added 6.61%
357,890 $25.6 Million
Q3 2017

Nov 07, 2017

SELL
$72.11 - $85.47 $15.3 Million - $18.2 Million
-212,700 Reduced 38.79%
335,690 $27.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
548,390
548,390 $38.8 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sector Gamma As Portfolio

Follow Sector Gamma As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.